Quantum redactiones paginae "Anandamidum" differant

E Vicipaedia
Content deleted Content added
pag. inst.
 
mNo edit summary
Linea 4: Linea 4:
! colspan="2" | Cognitores
! colspan="2" | Cognitores
|-
|-
| style="font-size: 85%" | ''[[ChemSpider]]'' || style="font-size: 85%" | [http://www.chemspider.com/Chemical-Structure. 4445241.html 4445241]
| style="font-size: 85%" | ''[[ChemSpider]]'' || style="font-size: 85%" | [http://www.chemspider.com/Chemical-Structure.4445241.html 4445241]
|-
|-
| style="font-size: 85%" | [[PubChem]] || style="font-size: 85%" | [https://pubchem.ncbi.nlm.nih.gov/compound/5281969 5281969]
| style="font-size: 85%" | [[PubChem]] || style="font-size: 85%" | [https://pubchem.ncbi.nlm.nih.gov/compound/5281969 5281969]
Linea 21: Linea 21:


Effectus anandamidi cum praesentia [[receptorium cannabinoideum|receptoriorum cannabinoideorum]] nexi sunt. Putatur quoque anandamido effectus in [[morbus mentis|morbis mentis]] esse<ref>{{cite journal |authors=Gaetani S., Dipasquale P., Romano A., Righetti L., Cassano T., Piomelli D., Cuomo V. |title=The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs |journal=International review of neurobiology |year=2009 |volume=85 |pages=57-72 |url=https://www.ncbi.nlm.nih.gov/pubmed/19607961}}</ref>.
Effectus anandamidi cum praesentia [[receptorium cannabinoideum|receptoriorum cannabinoideorum]] nexi sunt. Putatur quoque anandamido effectus in [[morbus mentis|morbis mentis]] esse<ref>{{cite journal |authors=Gaetani S., Dipasquale P., Romano A., Righetti L., Cassano T., Piomelli D., Cuomo V. |title=The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs |journal=International review of neurobiology |year=2009 |volume=85 |pages=57-72 |url=https://www.ncbi.nlm.nih.gov/pubmed/19607961}}</ref>.

== Natura chemica ==
Compositum est anandamidum longa ex molecula [[Acidum arachidonicum|acidi arachidonici]] per amino secundario cum [[ethanol|aaethanolo]] (aeathanolamino) coniunctum. Nomen [[IUPAC]] est (5Z,8Z,11Z,14Z)-''N''-(2-hydroxy-aethyl)-icosa-5,8,11,14-tetraenamidum.

<gallery>
Fasciculus:Arachidonic acid.svg|[[Acidum arachidonicum]]
Fasciculus:Secondary-amine-2D-general.svg|Aminum secundarium
Fasciculus:Ethanolamine-2D-skeletal-B.png|Aethanolaminum
Fasciculus:Ethanol-2D-skeletal.svg|[[ethanol|Aethanolum]]<br />([[alcohol primarium]])
Fasciculus:Primary-amine-2D-general.svg|Aminum primarium
</gallery>


== Notae ==
== Notae ==

Emendatio ex 08:38, 18 Ianuarii 2020

Anandamidum
Cognitores
ChemSpider 4445241
PubChem 5281969
Natura chemica
Anandamidum
Anandamidum
Formula summarum C
22
H
37
NO
2
Massa molaris 347.53 g/mol

Anandamidum vel N-arachidonoylaethanolaminum (AEA) est neurotransmissor et unctoacidum ab acido arachidonico, uno unctoacidorum omega-6 essentialium, derivatum. Pars nominis prima de Lingua Sanscrita (ananda = felicitas) Lingua Sanscrita.

Effectus anandamidi cum praesentia receptoriorum cannabinoideorum nexi sunt. Putatur quoque anandamido effectus in morbis mentis esse[1].

Natura chemica

Compositum est anandamidum longa ex molecula acidi arachidonici per amino secundario cum aaethanolo (aeathanolamino) coniunctum. Nomen IUPAC est (5Z,8Z,11Z,14Z)-N-(2-hydroxy-aethyl)-icosa-5,8,11,14-tetraenamidum.

Notae

  1. Gaetani S., Dipasquale P., Romano A., Righetti L., Cassano T., Piomelli D., Cuomo V. (2009). "The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs". International review of neurobiology 85: 57-72 

Bibliographia

  • Mechoulam R., Fride E.: The unpaved road to the endogenous brain cannabinoid ligands, the anandamides in “Cannabinoid Receptors” (ed. R. Pertwee), Academic Press, London. Pp. 233-258 (1995).

Nexus interni